Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 1
2011 5
2012 7
2013 5
2014 1
2015 5
2016 7
2017 4
2018 2
2019 1
2020 8
2021 10
2022 11
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease.
Gadelha M, Bex M, Feelders RA, Heaney AP, Auchus RJ, Gilis-Januszewska A, Witek P, Belaya Z, Yu Y, Liao Z, Ku CHC, Carvalho D, Roughton M, Wojna J, Pedroncelli AM, Snyder PJ. Gadelha M, et al. Among authors: witek p. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2882-e2895. doi: 10.1210/clinem/dgac178. J Clin Endocrinol Metab. 2022. PMID: 35325149 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Editorial: Insights Into Acromegaly Complications.
Badiu C, Witek P. Badiu C, et al. Among authors: witek p. Front Endocrinol (Lausanne). 2022 Jun 27;13:905145. doi: 10.3389/fendo.2022.905145. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35832422 Free PMC article. No abstract available.
Pasireotide-a novel somatostatin receptor ligand after 20 years of use.
Bolanowski M, Kałużny M, Witek P, Jawiarczyk-Przybyłowska A. Bolanowski M, et al. Among authors: witek p. Rev Endocr Metab Disord. 2022 Jun;23(3):601-620. doi: 10.1007/s11154-022-09710-3. Epub 2022 Jan 24. Rev Endocr Metab Disord. 2022. PMID: 35067849 Free PMC article. Review.
Medical treatment of Cushing's disease with concurrent diabetes mellitus.
Mehlich A, Bolanowski M, Mehlich D, Witek P. Mehlich A, et al. Among authors: witek p. Front Endocrinol (Lausanne). 2023 Apr 17;14:1174119. doi: 10.3389/fendo.2023.1174119. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37139336 Free PMC article. Review.
The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Pękul M, Zieliński G, Styk A, Kunicki J, Działach Ł, Witek P, Bujko M. Kober P, et al. Among authors: witek p. Front Endocrinol (Lausanne). 2023 Mar 29;14:1124646. doi: 10.3389/fendo.2023.1124646. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37065760 Free PMC article.
79 results